Each N-PORT filing of RSPH compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.https://themulden.com/enhttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/61 positions became 59: 0 added (0% of the fund), 2 dropped (3.47%). Turnover proxy 7.6%. Largest increases: Humana Inc. 1.25% to 2.45%; UnitedHealth Group Inc. 1.43% to 2.3%; Centene Corp. 1.83% to 2.65%; West Pharmaceutical Services, Inc. 1.42% to 2.21%; Elevance Health, Inc. 1.66% to 2.3%; CVS Health Corp. 1.55% to 1.95%. Largest decreases: Moderna, Inc. 2.49% to 1.45%; Gilead Sciences, Inc. 1.92% to 1.59%; HCA Healthcare, Inc. 1.71% to 1.43%; Vertex Pharmaceuticals Inc. 1.73% to 1.54%; Cardinal Health, Inc. 1.78% to 1.58%; Boston Scientific Corp. 1.65% to 1.46%. Gone: Molina Healthcare, Inc. (1.83%), Hologic, Inc. (1.64%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 26 Jun 2026 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/61 positions became 61: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.6%. Largest increases: Moderna, Inc. 1.78% to 2.49%; Baxter International Inc. 1.23% to 1.8%; DexCom, Inc. 1.22% to 1.77%; Molina Healthcare, Inc. 1.36% to 1.83%; Cigna Group (The) 1.29% to 1.71%; Gilead Sciences, Inc. 1.66% to 1.92%. Largest decreases: Intuitive Surgical, Inc. 1.9% to 1.48%; Universal Health Services, Inc. 1.86% to 1.48%; Humana Inc. 1.63% to 1.25%; Waters Corp. 1.91% to 1.53%; Agilent Technologies, Inc. 1.88% to 1.53%; West Pharmaceutical Services, Inc. 1.77% to 1.42%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 30 Mar 2026 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/61 positions became 61: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.4%. Largest increases: Centene Corp. 0.82% to 1.81%; Waters Corp. 1.45% to 1.91%; Align Technology, Inc. 1.21% to 1.66%; Molina Healthcare, Inc. 0.93% to 1.36%; Elevance Health, Inc. 1.29% to 1.65%; Intuitive Surgical, Inc. 1.6% to 1.9%. Largest decreases: DexCom, Inc. 1.69% to 1.22%; ResMed Inc. 1.88% to 1.46%; DaVita Inc. 1.76% to 1.44%; Boston Scientific Corp. 1.83% to 1.53%; Stryker Corp. 1.78% to 1.49%; Becton, Dickinson and Co. 1.79% to 1.52%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 29 Dec 2025 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/61 positions became 61: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 6.4%. Largest increases: Charles River Laboratories International, Inc. 1.2% to 1.95%; IQVIA Holdings Inc. 1.44% to 2.03%; Thermo Fisher Scientific Inc. 1.44% to 1.95%; Moderna, Inc. 1.4% to 1.85%; Bio-Techne Corp. 1.44% to 1.84%; Regeneron Pharmaceuticals, Inc. 1.49% to 1.83%. Largest decreases: Centene Corp. 1.76% to 0.82%; Molina Healthcare, Inc. 1.78% to 0.93%; Align Technology, Inc. 1.81% to 1.21%; Elevance Health, Inc. 1.76% to 1.29%; Cigna Group (The) 1.88% to 1.49%; Baxter International Inc. 1.56% to 1.2%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 26 Sep 2025 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/62 positions became 61: 0 added (0% of the fund), 1 dropped (1.57%). Turnover proxy 5.1%. Largest increases: Align Technology, Inc. 1.46% to 1.81%; Edwards Lifesciences Corp. 1.57% to 1.89%; ResMed Inc. 1.53% to 1.85%; Cigna Group (The) 1.6% to 1.88%; McKesson Corp. 1.65% to 1.91%; IDEXX Laboratories, Inc. 1.54% to 1.8%. Largest decreases: Thermo Fisher Scientific Inc. 1.79% to 1.44%; Revvity, Inc. 1.73% to 1.44%; GE HealthCare Technologies Inc. 1.7% to 1.44%; Bristol-Myers Squibb Co. 1.66% to 1.44%; Mettler-Toledo International Inc. 1.71% to 1.51%; Becton, Dickinson and Co. 1.79% to 1.59%. Gone: Teleflex Inc. (1.57%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Jun 2025 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/63 positions became 62: 0 added (0% of the fund), 1 dropped (1.68%). Turnover proxy 4.3%. Largest increases: Centene Corp. 1.41% to 1.8%; Elevance Health, Inc. 1.26% to 1.64%; DaVita Inc. 1.46% to 1.81%; Humana Inc. 1.37% to 1.68%; Thermo Fisher Scientific Inc. 1.53% to 1.79%; Teleflex Inc. 1.39% to 1.57%. Largest decreases: Incyte Corp. 1.99% to 1.63%; Viatris Inc. 1.7% to 1.41%; Bristol-Myers Squibb Co. 1.94% to 1.66%; Hologic, Inc. 1.7% to 1.52%; Charles River Laboratories International, Inc. 1.53% to 1.36%; Bio-Techne Corp. 1.69% to 1.53%. Gone: Catalent, Inc. (1.68%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 28 Mar 2025 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 63: 0 added (0% of the fund), 1 dropped (1.83%). Turnover proxy 5.5%. Largest increases: DexCom, Inc. 0.89% to 1.73%; Edwards Lifesciences Corp. 1.1% to 1.67%; Incyte Corp. 1.6% to 1.99%; West Pharmaceutical Services, Inc. 1.41% to 1.75%; Boston Scientific Corp. 1.47% to 1.72%; Insulet Corp. 1.48% to 1.69%. Largest decreases: Regeneron Pharmaceuticals, Inc. 1.59% to 1.24%; IQVIA Holdings Inc. 1.77% to 1.47%; Centene Corp. 1.71% to 1.41%; Elevance Health, Inc. 1.52% to 1.26%; Charles River Laboratories International, Inc. 1.78% to 1.53%; Universal Health Services, Inc. 1.74% to 1.5%. Gone: Bio-Rad Laboratories, Inc. (1.83%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Dec 2024 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/65 positions became 64: 1 added (1.65% of the fund), 2 dropped (3.05%). Turnover proxy 7.9%. Largest increases: Bio-Rad Laboratories, Inc. 1.3% to 1.83%; Bristol-Myers Squibb Co. 1.36% to 1.76%; Charles River Laboratories International, Inc. 1.43% to 1.78%; Gilead Sciences, Inc. 1.44% to 1.79%; GE HealthCare Technologies Inc. 1.35% to 1.69%; Waters Corp. 1.44% to 1.74%. Largest decreases: DexCom, Inc. 1.57% to 0.89%; Moderna, Inc. 1.78% to 1.3%; Edwards Lifesciences Corp. 1.53% to 1.1%; Merck & Co., Inc. 1.74% to 1.34%; ResMed Inc. 1.89% to 1.54%; Eli Lilly and Co. 1.7% to 1.4%. New: Labcorp Holdings Inc. (1.65%). Gone: Laboratory Corp. of America Holdings (1.54%), Illumina, Inc. (1.51%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 27 Sep 2024 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 65: 3 added (2.9% of the fund), 2 dropped (3.18%). Turnover proxy 6.7%. Largest increases: Quest Diagnostics Inc. 1.36% to 1.8%; Humana Inc. 1.13% to 1.48%; UnitedHealth Group Inc. 1.34% to 1.69%; DaVita Inc. 1.45% to 1.71%; Elevance Health, Inc. 1.49% to 1.75%; Pfizer Inc. 1.36% to 1.56%. Largest decreases: Catalent, Inc. 2.01% to 1.64%; Illumina, Inc. 1.83% to 1.51%; Align Technology, Inc. 1.74% to 1.5%; Bio-Rad Laboratories, Inc. 1.53% to 1.3%; Vertex Pharmaceuticals Inc. 1.79% to 1.58%; GE HealthCare Technologies Inc. 1.55% to 1.35%. New: Cooper Cos., Inc. (The) (1.46%), Solventum Corp. (1.43%), Invesco Government & Agency Portfolio (0.01%). Gone: Cooper Cos., Inc. (The) (1.61%), DENTSPLY SIRONA Inc. (1.58%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 26 Jun 2024 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 64: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.9%. Largest increases: Catalent, Inc. 1.22% to 2.01%; Align Technology, Inc. 0.96% to 1.74%; Illumina, Inc. 1.19% to 1.83%; Moderna, Inc. 1.22% to 1.82%; Revvity, Inc. 1.34% to 1.7%; HCA Healthcare, Inc. 1.42% to 1.71%. Largest decreases: Humana Inc. 1.93% to 1.13%; UnitedHealth Group Inc. 1.92% to 1.34%; Quest Diagnostics Inc. 1.76% to 1.36%; Molina Healthcare, Inc. 1.79% to 1.4%; CVS Health Corp. 1.81% to 1.43%; Gilead Sciences, Inc. 1.78% to 1.43%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 28 Mar 2024 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/65 positions became 64: 0 added (0% of the fund), 1 dropped (1.63%). Turnover proxy 6.5%. Largest increases: Humana Inc. 1.31% to 1.93%; UnitedHealth Group Inc. 1.5% to 1.92%; Centene Corp. 1.45% to 1.82%; McKesson Corp. 1.5% to 1.87%; Gilead Sciences, Inc. 1.43% to 1.78%; Biogen Inc. 1.28% to 1.58%. Largest decreases: Align Technology, Inc. 1.83% to 0.96%; Catalent, Inc. 1.84% to 1.22%; Bio-Rad Laboratories, Inc. 1.65% to 1.33%; IDEXX Laboratories, Inc. 1.8% to 1.48%; Revvity, Inc. 1.62% to 1.34%; Bio-Techne Corp. 1.56% to 1.31%. Gone: Organon & Co. (1.63%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 28 Dec 2023 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/66 positions became 65: 0 added (0% of the fund), 1 dropped (0%). Turnover proxy 4.7%. Largest increases: Catalent, Inc. 1.05% to 1.84%; Align Technology, Inc. 1.48% to 1.83%; Viatris Inc. 1.33% to 1.65%; Cigna Group (The) 1.31% to 1.63%; Bio-Rad Laboratories, Inc. 1.34% to 1.65%; IDEXX Laboratories, Inc. 1.54% to 1.8%. Largest decreases: Biogen Inc. 1.68% to 1.28%; Intuitive Surgical, Inc. 1.9% to 1.52%; Universal Health Services, Inc. 1.81% to 1.49%; Eli Lilly and Co. 1.78% to 1.49%; Humana Inc. 1.57% to 1.31%; Edwards Lifesciences Corp. 1.68% to 1.44%. Gone: Invesco Government & Agency Portfolio (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 28 Sep 2023 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/65 positions became 66: 1 added (1.61% of the fund), 0 dropped (0%). Turnover proxy 5.6%. Largest increases: Intuitive Surgical, Inc. 1.38% to 1.9%; Baxter International Inc. 1.33% to 1.78%; Eli Lilly and Co. 1.45% to 1.78%; Teleflex Inc. 1.5% to 1.74%; Molina Healthcare, Inc. 1.39% to 1.62%; DexCom, Inc. 1.4% to 1.6%. Largest decreases: Catalent, Inc. 1.82% to 1.05%; Align Technology, Inc. 2.18% to 1.48%; Charles River Laboratories International, Inc. 1.77% to 1.33%; Viatris Inc. 1.72% to 1.33%; Bio-Rad Laboratories, Inc. 1.72% to 1.34%; IQVIA Holdings Inc. 1.67% to 1.36%. New: Insulet Corp. (1.61%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 28 Jun 2023 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/65 positions became 65: 1 added (1.68% of the fund), 1 dropped (1.42%). Turnover proxy 9.1%. Largest increases: Align Technology, Inc. 1.17% to 2.18%; Catalent, Inc. 1.09% to 1.82%; Bio-Rad Laboratories, Inc. 1.1% to 1.72%; West Pharmaceutical Services, Inc. 1.17% to 1.69%; DaVita Inc. 1.25% to 1.69%; DENTSPLY SIRONA Inc. 1.44% to 1.86%. Largest decreases: Dexcom, Inc. 2.06% to 1.4%; Biogen Inc. 2.12% to 1.55%; Gilead Sciences, Inc. 1.91% to 1.45%; Humana Inc. 1.85% to 1.46%; Intuitive Surgical, Inc. 1.77% to 1.38%; Eli Lilly and Co. 1.81% to 1.45%. New: GE HealthCare Technologies Inc. (1.68%). Gone: ABIOMED, Inc. (1.42%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Fri, 31 Mar 2023 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/65 positions became 65: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 6.3%. Largest increases: Biogen Inc. 1.6% to 2.12%; Gilead Sciences, Inc. 1.45% to 1.91%; Dexcom, Inc. 1.65% to 2.06%; Viatris Inc. 1.28% to 1.63%; Universal Health Services, Inc. 1.44% to 1.79%; Merck & Co., Inc. 1.51% to 1.84%. Largest decreases: West Pharmaceutical Services, Inc. 1.72% to 1.17%; Bio-Rad Laboratories, Inc. 1.64% to 1.1%; Catalent, Inc. 1.56% to 1.09%; Align Technology, Inc. 1.61% to 1.17%; Edwards Lifesciences Corp. 1.59% to 1.18%; Bio-Techne Corp. 1.7% to 1.36%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 28 Dec 2022 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/66 positions became 65: 0 added (0% of the fund), 1 dropped (1.57%). Turnover proxy 5.7%. Largest increases: Align Technology, Inc. 1.13% to 1.61%; ResMed, Inc. 1.32% to 1.7%; Moderna, Inc. 1.53% to 1.9%; West Pharmaceutical Services, Inc. 1.36% to 1.72%; IDEXX Laboratories, Inc. 1.36% to 1.7%; HCA Healthcare, Inc. 1.26% to 1.59%. Largest decreases: Viatris, Inc. 1.62% to 1.28%; Baxter International, Inc. 1.45% to 1.18%; Merck & Co., Inc. 1.78% to 1.51%; Bristol-Myers Squibb Co. 1.71% to 1.45%; Elevance Health, Inc. 1.69% to 1.46%; DaVita, Inc. 1.55% to 1.33%. Gone: Cerner Corp. (1.57%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 27 Sep 2022 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 66: 2 added (1.61% of the fund), 0 dropped (0%). Turnover proxy 5%. Largest increases: Moderna, Inc. 1.06% to 1.53%; DexCom, Inc. 1.22% to 1.64%; Humana, Inc. 1.37% to 1.64%; Bio-Rad Laboratories, Inc. 1.29% to 1.52%; Bio-Techne Corp. 1.3% to 1.49%; Quest Diagnostics, Inc. 1.36% to 1.54%. Largest decreases: Cerner Corp. 1.97% to 1.57%; Organon & Co. 1.79% to 1.42%; Universal Health Services, Inc. 1.63% to 1.28%; DENTSPLY SIRONA, Inc. 1.61% to 1.29%; HCA Healthcare, Inc. 1.59% to 1.26%; Viatris, Inc. 1.9% to 1.62%. New: Molina Healthcare, Inc. (1.57%), Invesco Government & Agency Portfolio (0.04%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 27 Jun 2022 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/65 positions became 64: 0 added (0% of the fund), 1 dropped (0%). Turnover proxy 5.2%. Largest increases: Cerner Corp. 1.58% to 1.97%; Bristol-Myers Squibb Co. 1.47% to 1.85%; Viatris, Inc. 1.53% to 1.9%; Incyte Corp. 1.49% to 1.83%; Vertex Pharmaceuticals, Inc. 1.56% to 1.88%; DaVita, Inc. 1.33% to 1.65%. Largest decreases: DexCom, Inc. 1.8% to 1.22%; Humana, Inc. 1.83% to 1.37%; Intuitive Surgical, Inc. 1.68% to 1.33%; Bio-Techne Corp. 1.61% to 1.3%; Thermo Fisher Scientific, Inc. 1.76% to 1.46%; Centene Corp. 1.89% to 1.6%. Gone: Invesco Government & Agency Portfolio (0%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Thu, 31 Mar 2022 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 65: 2 added (1.61% of the fund), 1 dropped (1.47%). Turnover proxy 6.6%. Largest increases: Centene Corp. 1.42% to 1.89%; Anthem, Inc. 1.46% to 1.93%; Merck & Co., Inc. 1.47% to 1.9%; Humana, Inc. 1.49% to 1.83%; UnitedHealth Group, Inc. 1.52% to 1.81%; Organon & Co. 1.43% to 1.72%. Largest decreases: Moderna, Inc. 1.69% to 1.22%; ResMed, Inc. 1.82% to 1.41%; PerkinElmer, Inc. 1.82% to 1.5%; Waters Corp. 1.7% to 1.39%; Align Technology, Inc. 1.66% to 1.37%; Hologic, Inc. 1.73% to 1.45%. New: Bio-Techne Corp. (1.61%), Invesco Government & Agency Portfolio (0%). Gone: Perrigo Co. PLC (1.47%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 29 Dec 2021 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/62 positions became 64: 3 added (4.81% of the fund), 1 dropped (1.68%). Turnover proxy 6.9%. Largest increases: Hologic, Inc. 1.4% to 1.73%; ResMed, Inc. 1.53% to 1.82%; Eli Lilly and Co. 1.32% to 1.59%; DexCom, Inc. 1.63% to 1.89%; PerkinElmer, Inc. 1.59% to 1.82%; Illumina, Inc. 1.46% to 1.6%. Largest decreases: IQVIA Holdings, Inc. 1.89% to 1.49%; Biogen, Inc. 1.51% to 1.2%; Baxter International, Inc. 1.66% to 1.38%; Incyte Corp. 1.63% to 1.37%; Mettler-Toledo International, Inc. 1.86% to 1.63%; Anthem, Inc. 1.67% to 1.46%. New: Charles River Laboratories International, Inc. (1.69%), Moderna, Inc. (1.69%), Organon & Co. (1.43%). Gone: Alexion Pharmaceuticals, Inc. (1.68%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 28 Sep 2021 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 62: 0 added (0% of the fund), 2 dropped (1.56%). Turnover proxy 5%. Largest increases: Pfizer, Inc. 1.32% to 1.67%; Mettler-Toledo International, Inc. 1.55% to 1.86%; IQVIA Holdings, Inc. 1.61% to 1.89%; Intuitive Surgical, Inc. 1.49% to 1.78%; Edwards Lifesciences Corp. 1.49% to 1.75%; Zoetis, Inc. 1.47% to 1.71%. Largest decreases: Eli Lilly and Co. 1.97% to 1.32%; ABIOMED, Inc. 2.05% to 1.59%; Illumina, Inc. 1.89% to 1.46%; Biogen, Inc. 1.78% to 1.51%; Alexion Pharmaceuticals, Inc. 1.93% to 1.68%; Hologic, Inc. 1.63% to 1.4%. Gone: Varian Medical Systems, Inc. (1.53%), Invesco Government & Agency Portfolio (0.03%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 29 Jun 2021 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/64 positions became 64: 1 added (1.49% of the fund), 1 dropped (1.51%). Turnover proxy 6.3%. Largest increases: Eli Lilly and Co. 1.41% to 1.97%; ABIOMED, Inc. 1.49% to 2.05%; Illumina, Inc. 1.33% to 1.89%; DexCom, Inc. 1.33% to 1.64%; Biogen, Inc. 1.49% to 1.78%; Vertex Pharmaceuticals, Inc. 1.29% to 1.55%. Largest decreases: Align Technology, Inc. 2.14% to 1.58%; Bio-Rad Laboratories, Inc. 1.85% to 1.54%; ResMed, Inc. 1.78% to 1.5%; IDEXX Laboratories, Inc. 1.86% to 1.59%; Pfizer, Inc. 1.57% to 1.32%; Anthem, Inc. 1.69% to 1.45%. New: Viatris, Inc. (1.49%). Gone: Mylan N.V. (1.51%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 31 Mar 2021 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/62 positions became 64: 2 added (1.71% of the fund), 0 dropped (0%). Turnover proxy 5.1%. Largest increases: Align Technology, Inc. 1.7% to 2.14%; Alexion Pharmaceuticals, Inc. 1.36% to 1.74%; Cigna Corp. 1.32% to 1.57%; STERIS PLC 1.53% to 1.74%; DENTSPLY SIRONA, Inc. 1.5% to 1.71%; Anthem, Inc. 1.5% to 1.69%. Largest decreases: DexCom, Inc. 1.71% to 1.33%; HCA Healthcare, Inc. 1.83% to 1.48%; West Pharmaceutical Services, Inc. 1.95% to 1.59%; ABIOMED, Inc. 1.81% to 1.49%; Illumina, Inc. 1.63% to 1.33%; Edwards Lifesciences Corp. 1.68% to 1.4%. New: Catalent, Inc. (1.69%), Invesco Government & Agency Portfolio (0.02%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Wed, 30 Dec 2020 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/60 positions became 62: 3 added (5.36% of the fund), 1 dropped (1.67%). Turnover proxy 7.3%. Largest increases: ResMed, Inc. 1.57% to 1.83%; HCA Healthcare, Inc. 1.58% to 1.83%; Intuitive Surgical, Inc. 1.62% to 1.79%; IDEXX Laboratories, Inc. 1.74% to 1.91%; Becton, Dickinson and Co. 1.61% to 1.77%; Varian Medical Systems, Inc. 1.65% to 1.8%. Largest decreases: Alexion Pharmaceuticals, Inc. 1.73% to 1.36%; Cigna Corp. 1.68% to 1.32%; Gilead Sciences, Inc. 1.67% to 1.38%; Mylan N.V. 1.73% to 1.47%; Quest Diagnostics, Inc. 1.92% to 1.67%; Anthem, Inc. 1.75% to 1.5%. New: West Pharmaceutical Services, Inc. (1.95%), DexCom, Inc. (1.71%), Bio-Rad Laboratories, Inc. (1.7%). Gone: Allergan PLC (1.67%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 28 Sep 2020 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/60 positions became 60: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3%. Largest increases: Incyte Corp. 1.34% to 1.63%; Align Technology, Inc. 1.62% to 1.85%; Alexion Pharmaceuticals, Inc. 1.51% to 1.73%; Hologic, Inc. 1.68% to 1.91%; ABIOMED, Inc. 1.71% to 1.92%; Illumina, Inc. 1.49% to 1.68%. Largest decreases: Eli Lilly and Co. 1.92% to 1.64%; Cooper Cos., Inc. (The) 1.83% to 1.56%; Centene Corp. 1.82% to 1.56%; Vertex Pharmaceuticals, Inc. 1.73% to 1.55%; Baxter International, Inc. 1.78% to 1.59%; ResMed, Inc. 1.73% to 1.57%. Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Mon, 29 Jun 2020 12:00:00 GMThttps://themulden.com/funds/rsph/https://themulden.com/funds/rsph/61 positions became 60: 1 added (1.66% of the fund), 2 dropped (3.5%). Turnover proxy 7.1%. Largest increases: Mylan N.V. 1.4% to 1.87%; Baxter International, Inc. 1.4% to 1.78%; DaVita, Inc. 1.5% to 1.84%; Cooper Cos., Inc. (The) 1.53% to 1.83%; Eli Lilly and Co. 1.63% to 1.92%; IQVIA Holdings, Inc. 1.51% to 1.79%. Largest decreases: Align Technology, Inc. 2.26% to 1.62%; Biogen, Inc. 2% to 1.51%; Incyte Corp. 1.74% to 1.34%; AbbVie, Inc. 1.79% to 1.54%; Regeneron Pharmaceuticals, Inc. 1.73% to 1.5%; Amgen, Inc. 1.73% to 1.53%. New: STERIS PLC (1.66%). Gone: WellCare Health Plans, Inc. (1.76%), Celgene Corp. (1.74%). Weights are shares of the fund's own investments, securities-lending collateral excluded; positions matched on identifiers.Tue, 31 Mar 2020 12:00:00 GMT